Dimensional Fund Advisors
KYTX icon

Dimensional Fund Advisors’s Kyverna Therapeutics KYTX Stock Holding History

Dimensional Fund Advisors’s Portfolio KYTX Stock Details KYTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$699K Hold
78,419
– – ﹤0.01% 2920
2026
Q1 		$677K Buy
78,419
+6
+0% +$50 ﹤0.01% 2910
2025
Q4 		$737K Buy
+78,413
New +$582K ﹤0.01% 2907

Other funds holding KYTX

GGI
GordonMD Global Investments Beverely Hills, California $207M AUM
GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
IHG
Insight Holdings Group New York $1.32B AUM 1.62% 1-Year Est. Return

Dimensional Fund Advisors's KYTX Position: Q2 2026 in Review

Dimensional Fund Advisors held its Kyverna Therapeutics (KYTX) position steady in Q2 2026 at 78,419 shares worth $699K. The position accounts for ﹤0.01% of the portfolio, ranked #2920.

Dimensional Fund Advisors first reported a position in KYTX in Q4 2025 and has held it in 3 quarters since. The position peaked at $737K in Q4 2025. 120 funds tracked by Wall St. Rank hold KYTX as of Q2 2026.

  • Dimensional Fund Advisors held 78,419 shares of Kyverna Therapeutics worth $699K as of Q2 2026.
  • Dimensional Fund Advisors left its Kyverna Therapeutics share count unchanged in Q2 2026.
  • Kyverna Therapeutics made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q2 2026, its #2920 holding.
  • Dimensional Fund Advisors first reported a position in Kyverna Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • Dimensional Fund Advisors's Kyverna Therapeutics position peaked at $737K in Q4 2025.
  • 120 funds tracked by Wall St. Rank held Kyverna Therapeutics as of Q2 2026.

Based on Dimensional Fund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.